<DOC>
	<DOCNO>NCT01527123</DOCNO>
	<brief_summary>This Phase 1 , single-center , open-label study evaluate pharmacokinetics BPO metabolites benzoic acid hippuric acid 7-day repeat application GSK2585823 subject acne vulgaris</brief_summary>
	<brief_title>A Study Evaluate Pharmacokinetics Benzoic Acid Hippuric Acid After Topical Administration GSK2585823 Japanese Subjects With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoic Acid</mesh_term>
	<criteria>Japanese male female subject 20 45 year age inclusive time signing informed consent . Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . Diagnosis acne vulgaris dermatologist . Other acne vulgaris subject must good general condition determine investigator , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . Subjects must , face screening ( physical examination dermatologist ) : A minimum 17 60 inflammatory acne lesion ( papule / pustule ) , include nasal lesion ; minimum 20 150 noninflammatory acne lesion ( open / close comedo ) , include nasal lesion . It set evaluate acne patient degree severity Japanese Phase 3 study . A female subject eligible participate : Childbearing potential agrees use one contraception method list protocol appropriate period time ( determined product label investigator ) prior start dose sufficiently minimize risk pregnancy point . Female subject must agree use contraception followup examination . Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . Body weight great equal 50 kg body mass index ( BMI ) within range great equal to18.5 le 29.0 kg/m2 screen Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . Capable give write informed consent , include compliance requirement restriction list consent form . Rationale : It include ethical viewpoint accord GCP . Single QTcB le 450 msec ; QTc le 480 msec subject Bundle Branch Block . Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . AST , ALT , alkaline phosphatase total bilirubin les equal ULN screening . Rationale : It consider adult qualify maximum age expect subject acne vulgaris good health . Exclusion criterion : Have history presence regional enteritis , inflammatory bowel disease ( e.g. , ulcerative colitis , pseudomembranous colitis , chronic diarrhea , antibioticassociated colitis bloody diarrhea ) similar symptom . Rationale : It consider necessary secure subject 's safety . Pregnant female determine positive urine hCG test screen lactate female . Rationale : It consider necessary secure subject 's safety . Used follow agent face within previous 2 week : Topical antibiotic ( systemic antibiotic ) ; Topical antiacne medication ( e.g. , BPO , azelaic acid , resorcinol , salicylates ) ; Abradants , facial , peel contain glycolic acid ; Masks , wash soap contain BPO , sulfacetamide sodium , salicylic acid ; Nonmild facial cleanser ( e.g. , facial scrub , cleanser contain agent antiinflammatory action ) ; Moisturizers contain retinol , salicylic acid , α βhydroxy acid ; Astringents toner ( Subjects allow enroll study , subject treatment 2 consecutive week prior start investigational product use ) ; Topical corticosteroid ( Use inhale , intraarticular , intralesional steroid facial acne acceptable ) ; Facial procedure ( chemical laser peel , microdermabration , blue light treatment , etc . ) ; Topical retinoids face Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Used systemic retinoids within previous 6 month . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Received treatment estrogen , androgen , antiandrogenic agent within previous 12 week ( Subjects treat agent 12 consecutive week prior start investigational product allow enrol long expect change dose , drug , discontinue use study ) . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Used medication opinion investigator may affect clinical study evaluation study . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Have know hypersensitivity previous allergic reaction component investigational product . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Used investigational therapy within previous 4 month , plan participate another clinical study time . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . A positive test syphilis , HBs antigen , HCV antibody , HIV antibody , HTLV1 antibody screen . Rationale : To secure site staff ' safety . A positive drug screen screen . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . Participated Japanese clinical study plan GlaxoSmithKline K.K . development investigational product acne vulgaris . Rationale : To incompatible stop criterion . Are currently abuse drug alcohol . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study avoid doublecount subject . Have significant medical history immunocompromised . Rationale : It consider necessary secure subject 's safety appropriately assess safety pharmacokinetics GSK2585823 study . People follow family member ; Employees GlaxoSmithKline , contract research organization ( CRO ) site management organization ( SMO ) ; Investigators ( subinvestigators ) . Rationale : : It consider necessary secure subject 's safety . The subject donate unit blood `` &gt; 400 mL '' within previous 4 month `` &gt; 200 mL '' within previous 1 month . Rationale : It consider necessary secure subject 's safety . It include ethical viewpoint . Painters subject work coat industry include automobile mechanic . Rationale : : It consider necessary secure subject 's safety . Unwillingness inability follow procedure outline protocol . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study avoid subject potentially high level blood concentration benzoic acid . Subject mentally legally incapacitate . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study . Have condition would put subject unacceptable risk participation study . Rationale : It consider necessary appropriately assess safety pharmacokinetics GSK2585823 study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>GSK2585823 , benzoic acid , hippuric acid , acne vulgaris , pharmacokinetics</keyword>
</DOC>